# A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

> **NCT00109083** · PHASE2 · COMPLETED · sponsor: **SK Life Science, Inc.** · enrollment: 300 (—)

## Conditions studied

- Migraine Headaches

## Interventions

- **DRUG:** RWJ-333369

## Key facts

- **NCT ID:** NCT00109083
- **Lead sponsor:** SK Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 300 (—)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109083, "A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00109083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*